国产bbaaaaa片,成年美女黄网站色视频免费,成年黄大片,а天堂中文最新一区二区三区,成人精品视频一区二区三区尤物

首頁> 美國衛(wèi)生研究院文獻>Diagnostics >Bolus Intravenous Procainamide in Patients with Frequent Ventricular Ectopics during Cardiac Magnetic Resonance Scanning: A Way to Ensure High Quality Imaging
【2h】

Bolus Intravenous Procainamide in Patients with Frequent Ventricular Ectopics during Cardiac Magnetic Resonance Scanning: A Way to Ensure High Quality Imaging

機譯:推注靜脈內(nèi)普魯卡因患者在心臟磁共振掃描期間經(jīng)常心室異位物質(zhì):一種保證高質(zhì)量成像的方法

代理獲取
本網(wǎng)站僅為用戶提供外文OA文獻查詢和代理獲取服務(wù),本網(wǎng)站沒有原文。下單后我們將采用程序或人工為您竭誠獲取高質(zhì)量的原文,但由于OA文獻來源多樣且變更頻繁,仍可能出現(xiàn)獲取不到、文獻不完整或與標題不符等情況,如果獲取不到我們將提供退款服務(wù)。請知悉。

摘要

Acquiring high-quality cardiac magnetic resonance (CMR) images in patients with frequent ventricular arrhythmias remains a challenge. We examined the safety and efficacy of procainamide when administered on the scanner table prior to CMR scanning to suppress ventricular ectopy and acquire high-quality images. Fifty consecutive patients (age 53.0 [42.0–58.0]; 52% female, left ventricular ejection fraction 55 ± 9%) were scanned in a 1.5 T scanner using a standard cardiac protocol. Procainamide was administered at intermittent intravenous bolus doses of 50 mg every minute until suppression of the ectopics or a maximum dose of 10 mg/kg. The average dose of procainamide was 567 ± 197 mg. Procainamide successfully suppressed premature ventricular contractions (PVCs) in 82% of patients, resulting in high-quality images. The baseline blood pressure (BP) was mildly reduced (mean change systolic BP ?12 ± 9 mmHg; diastolic BP ?4 ± 9 mmHg), while the baseline heart rate (HR) remained relatively unchanged (mean HR change ?1 ± 6 bpm). None of the patients developed proarrhythmic changes. Bolus intravenous administration of procainamide prior to CMR scanning is a safe and effective alternative approach for suppressing PVCs and acquiring high-quality images in patients with frequent PVCs and normal or only mildly reduced systolic function.
機譯:在頻繁心律失常心律失常患者中獲取高質(zhì)量的心臟磁共振(CMR)圖像仍然是一個挑戰(zhàn)。在CMR掃描之前在掃描儀表上施用掃描儀表時,我們檢查了普魯卡酰胺的安全性和有效性,以抑制心室偏見并獲得高質(zhì)量圖像。五十次連續(xù)患者(53.0歲[42.0-58.0];使用標準心臟協(xié)方案,在1.5 T掃描儀中掃描52%的雌性,左心室噴射級分55±9%)。在每分鐘的間歇靜脈注射劑量劑量為50mg的間歇靜脈注射劑量,直至抑制異位物或最大劑量為10mg / kg。 Procainamide的平均劑量為567±197毫克。 Procabainamide在82%的患者中成功地抑制過早的心室收縮(PVC),導(dǎo)致高質(zhì)量的圖像?;€血壓(BP)溫和地減少(平均變化收縮率BP -12±9 mmHg;舒張壓BP -4±9 mmHg),而基線心率(HR)保持相對不變(平均HR改變-1±6 bpm )。沒有患者產(chǎn)生過正常變化。在CMR掃描之前,推注靜脈內(nèi)施用Procainamide是一種安全有效的替代方法,用于抑制PVC,并在頻繁的PVC患者中獲取高質(zhì)量圖像,并且正?;騼H輕微降低的收縮功能。

著錄項

相似文獻

  • 外文文獻
  • 中文文獻
  • 專利
代理獲取

客服郵箱:kefu@zhangqiaokeyan.com

京公網(wǎng)安備:11010802029741號 ICP備案號:京ICP備15016152號-6 六維聯(lián)合信息科技 (北京) 有限公司?版權(quán)所有
  • 客服微信

  • 服務(wù)號